| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |